CAS: 20426-12-4; 3-(4-Hydroxyphenyl)-1-Phenylprop-2-En-1-One

该化合物是一种属于查尔科尼家族的有机化合物,其结构包括一个苯球氢氧基和一个氯酮组,通常看起来像一个黄色至橙色晶状固体,以其在各种生物系统中作为氟氯素前体的作用而著称;该化合物具有显著的抗氧化特性,有助于其潜在的健康利益,包括防炎和抗微生物活动;4-Hydroxychalcone在乙醇和乙醇等有机溶剂中可溶解,但在水中溶解性有限;其化学配方为C15H12O3,其分子重量反映了其碳,氢和氧原子的构成;该化合物既对合成有机化学和药理学都感兴趣,因为它可以作为合成更复杂的氟氯素的建筑块,并可用于治疗剂的发展;此外,其结构特征允许各种化学改变,加强其在研究和工业中的效用.

结构式图片

欧盟法规

ECHA物质C&L通报

上下游产品

CAS号123-08-0 4-羟基苯甲醛; 对羟基苯甲醛 | CAS号98-86-2 苯乙酮 | CAS号22252-15-9 4-甲氧基查耳酮 | CAS号70-11-1 2-溴苯乙酮 | CAS号13735-81-4 1-苯基-1-三甲基硅氧乙烯 | CAS号614-47-1 反-查耳酮 | CAS号123-08-0 4-羟基苯甲醛; 对羟基苯甲醛 | CAS号98-86-2 苯乙酮 | CAS号17791-25-2 3-(4-hydroxyphe... | CAS号74629-69-9 4-(4-phenyl-2,3...

合成工艺路线路线简述

    4-Methoxymethoxy-Benzaldehyde置于盐酸,水,Sodium Hydroxide体系中,用 乙醇 用作溶剂,化学反应 48.0H,反应生成2-羟基查耳酮
    参考文献:Design,Synthesis And Bioactivity Of Chalcones And Its Analogues
    标题:Design,Synthesis And Bioactivity Of Chalcones And Its Analogues
    摘要:The Vernohia Anthelmintica L'S Extract Is One Of The Most Popular Uygur Medicines Used For Vitiligo. It Is Believed That The Chalcone Compounds Of The Plant Play An Important Role In The Treatment Since They May Activate Tyrosinase And Improve Melanin Production. In This Study,Twenty-One Chalcones And Nine Analogues Were Synthesized In View Of Three Different Components Of Chalcone (A,B Ring And A,Beta-Unsaturated Carbonyl). After Biological Evaluation Of Their Activity On Tyrosinase In Cell-Free Systems,The Result Showed That Most Compounds (Except Polyhydroxy Chalcones) Possess Activator Effect On The Tyrosinase,Especially For 13A-15A,20A And 1 B,Which Bearing A Comparable Activity To The Positive Control 8-Mop. Sar Of These Tyrosinase Activator Was Summed Up For The First Time As Well. Finally,Compound 13A Was Found To Increase Melanin Contents And Tyrosinase Activity 1.75 And 1.3 Fold,Respectively,Compared With That Of Untreated Murine B16 Cells At The Concentration Of 40 Mu G/ml (C) 2017 Chinese Chemical Society And Institute Of Materia Medica,Chinese Academy Of Medical Sciences. Published By Elsevier B.V. All Rights Reserved.
    Doi:10.1016/j.Cclet.2017.03.018

    海关参考信息

    专利信息


    专利号:US-7851654-B2
    优先权日:2006-04-03
    标题 :Chalcone derivatives, pharmaceutically acceptable salt, method for preparation and uses thereof
    发明人:PARK KI HUN; KIM JIN HYO; SEO WOO DUCK; RYU YOUNG BAE; RYU HYUNG WON; LEE WOO SONG; GAL SANG WAN
    权利人:IND ACADEMIC COOP
    摘要:Disclosed relates to a novel chalcone derivative, pharmaceutically acceptable salt thereof, a method for preparing the same and uses thereof, the chalcone derivative being readily obtained through the steps of: reacting aminoacetophenone with sulfonylchloride under the presence of an appropriate salt; and reacting the compound prepared in the above step with hydroxybenzaldehide under the presence of an appropriate catalyst. The chalcone derivative of formula 1 in accordance with the present invention having strong enzyme inhibitory activities for glycosidase can be effectively used in preventing and treating various diseases induced by glycosidase, and the chalcone derivative of the invention having tyrosinase and melanin synthesis inhibitory activities can be effectively used as a skin-whitening compound.

    专利号:CN-110041198-B
    优先权日:2019-04-03
    标题:Synthesis method of chalcone-containing aryloxycarboxylate compound and application of the compound in pesticide
    连云港科联化工有限公司
    ⚠️ 未注册 · 未认证企业
    ⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
    数据来源于公开网络搜索,平台未作核实,请自行辨别。
    🏢敬请 企业认领
    🏬开设公司展台
    📢获取免费会员权益
    🎖️点亮专属注册企业标签
    📇展现公司完整信息 样本查看立即注册认领 →
    网址: http://www.klinechem.com
    企业联系👤
    📞连云港科联化工有限公司 ⚠️参考联系方式
    联系人:李先生

    手机:86-18014602686
    传真:86-518-88103267
    邮箱:sales@klinechem.com
    通信地址: 江苏省连云港市灌云县临港产业区纬五路经七路
    邮编: 222000
    🆔 联系时候可告知是从"百琢研"平台获取的信息.
    ⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

    地址:江苏省连云港市灌云县临港产业区纬五路经七路
    ⚠️ 未注册 · 未认证企业
    注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别
    ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
    第 1 / 1 页
    现货

    供应商参考报价(招募中)

    品牌试剂参考报价(招募中)

    📌 第三方产品分析报告

    ✅ COA系统入驻 | 共享模式

    合成参考文献


    摘要:González-Bello, C., Science of Synthesis Knowledge Updates, (2018) 3, 439.
    摘要:Primer, D. N.; Molander, G. A., Science of Synthesis, (2019) , 322.
    摘要:S109 | PARCEDC | List of 7074 potential endocrine disrupting compounds (EDCs) by PARC T4.2 | DOI:10.5281/zenodo.10944198
    📝 需求与反馈
    尽可能描述清楚需求与问题信息
    ×

    通知